Lesley A McNamara Selected Research

2- (2- chloro- 5- ((3- (4- chlorophenoxy)- 2- methyl- 6- (trifluoromethoxy)- 1H- indol- 1- yl)methyl)phenoxy)propionic acid

4/2008

A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lesley A McNamara Research Topics

Disease

2	Type 2 Diabetes Mellitus (MODY) 10/2013 - 04/2008
1	Vascular Remodeling 01/2019
1	Edema (Dropsy) 01/2019
1	Weight Gain 01/2019
1	Diabetes Mellitus 10/2013
1	Cardiomegaly (Heart Hypertrophy) 04/2008
1	Insulin Resistance 04/2008
1	Hyperlipidemias (Hyperlipidemia) 04/2008

Drug/Important Bio-Agent (IBA)

2	Insulin (Novolin)FDA Link 01/2019 - 04/2008
2	Rosiglitazone (Avandia)FDA Link 01/2019 - 04/2008
1	ThiazolidinedionesIBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 10/2013
1	Glucagon (Glukagon)FDA Link 10/2013
1	Glucagon Receptors (Glucagon Receptor)IBA 10/2013
1	2,4-thiazolidinedione (thiazolidinedione)IBA 04/2008
1	2- (2- chloro- 5- ((3- (4- chlorophenoxy)- 2- methyl- 6- (trifluoromethoxy)- 1H- indol- 1- yl)methyl)phenoxy)propionic acidIBA 04/2008
1	Pioglitazone (Actos)FDA Link 04/2008

Therapy/Procedure

1	Glycemic Control 04/2008